These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Aug. 28 through Sept. 3, 2025. Source: VerityData
Original Filings
ZoomInfo Technologies $(GTM)$ HighSage Ventures disclosed a new position in the media and information services company of 16,910,148 shares. HighSage Ventures purchased 5,725,000 of those shares from Aug. 6 through Aug. 20, 2025, at per share prices ranging from $9.63 to $10.57. Following the latest purchases, HighSage Ventures owns an initial 5.3% stake in ZoomInfo Technologies' outstanding stock. Shares of ZoomInfo Technologies have remained mostly flat since the beginning of this year.
International Money Express $(IMXI)$ Magnetar Financial disclosed a new position in the money transfer services company of 1,583,685 shares. Magnetar Financial purchased 1,598,117 International Money Express shares from June 27 through Aug. 28, 2025, at per share prices ranging from $8.58 to $14.97, but offset some of those purchases through the sale of 64,400 shares from July 1 to Aug. 12 at $8.58 to $15.15. Magnetar is likely making an arbitrage play, as on Aug. 10, International Money Express announced that it had entered into a definitive agreement to be acquired by Western Union for $16 per share in cash, valuing the deal at approximately $500 million. Following the purchases, Magnetar owns an initial 5.3% stake of International Money Express' outstanding stock.
Decreases in Holdings
Appian $(APPN)$ Abdiel Capital Advisors lowered its stake in the business process management platform to 2,111,093 shares. Abdiel Capital Advisors did so through the sale of 700,837 Appian shares from Aug. 22 through Aug. 27, 2025, at per share prices ranging from $28.55 to $30.14. Following the latest sales, Abdiel Capital Advisors continues to own 4.9% of Appian's outstanding stock, placing Abdiel below the 5% threshold that would require it to report further sales. Shares of Appian have lost approximately 7.3% of their value since the start of this year.
GeneDx Holdings (WGS) CMLS Holdings reduced its stake in the health-intelligence company to 3,630,826 shares. CMLS Holdings did so through the sale of 500,000 GeneDx shares on Aug. 22, 2025, at a price of $120.90 per share. Following the latest sales, CMLS Holdings continues to own 12.5% of GeneDx Holdings' outstanding stock. Shares of GeneDx Holdings have gained roughly 59.8% in value since the beginning of this year.
Stoke Therapeutics $(STOK)$ Skorpios Trust lowered its stake in the biotechnology company to 2,256,181 shares. Skorpios Trust did so through the sale of 1,000,000 Stoke Therapeutics shares on Aug. 22, 2025, at a price of $18.50 per share. Following the latest sales, Skorpios Trust continues to own 4.1% of Stoke Therapeutics' outstanding stock, placing Skorpios below the 5% threshold that would require it to report further sales. Shares of Stoke Therapeutics have gained about 75.4% in value since the beginning of this year.
Email: editors@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 05, 2025 16:16 ET (20:16 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.